Cargando…

Immunity to α-Gal: The Opportunity for Malaria and Tuberculosis Control

Detalles Bibliográficos
Autores principales:	Cabezas-Cruz, Alejandro, de la Fuente, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723007/ https://www.ncbi.nlm.nih.gov/pubmed/29255472 http://dx.doi.org/10.3389/fimmu.2017.01733

Ejemplares similares

Immunity to glycan α-Gal and possibilities for the control of COVID-19
por: de la Fuente, José, et al.
Publicado: (2020)

Immunity to α-Gal: Toward a Single-Antigen Pan-Vaccine To Control Major Infectious Diseases
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2017)

Environmental and Molecular Drivers of the α-Gal Syndrome
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2019)

The α-Gal Syndrome and Potential Mechanisms
por: Román-Carrasco, Patricia, et al.
Publicado: (2021)

Effect of blood type on anti-α-Gal immunity and the incidence of infectious diseases
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2017)

Vaccination with Alpha-Gal Protects Against Mycobacterial Infection in the Zebrafish Model of Tuberculosis
por: Pacheco, Iván, et al.
Publicado: (2020)

The alpha-Gal syndrome: new insights into the tick-host conflict and cooperation
por: de la Fuente, José, et al.
Publicado: (2019)

Tick Bites Induce Anti-α-Gal Antibodies in Dogs
por: Hodžić, Adnan, et al.
Publicado: (2019)

Exploring the Ecological Implications of Microbiota Diversity in Birds: Natural Barriers Against Avian Malaria
por: Palinauskas, Vaidas, et al.
Publicado: (2022)

Probiotic Bacteria with High Alpha-Gal Content Protect Zebrafish against Mycobacteriosis
por: Pacheco, Iván, et al.
Publicado: (2021)

Poly-L-Lysine-Based αGal-Glycoconjugates for Treating Anti-αGal IgE-Mediated Diseases
por: Olivera-Ardid, Sara, et al.
Publicado: (2022)

Removal of natural anti-αGal antibodies elicits protective immunity against Gram-negative bacterial infections
por: Olivera-Ardid, Sara, et al.
Publicado: (2023)

Functional characterization of α-Gal producing lactic acid bacteria with potential probiotic properties
por: Bamgbose, Timothy, et al.
Publicado: (2022)

Tick galactosyltransferases are involved in α-Gal synthesis and play a role during Anaplasma phagocytophilum infection and Ixodes scapularis tick vector development
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2018)

Fasciola hepatica Immune Regulates CD11c(+) Cells by Interacting with the Macrophage Gal/GalNAc Lectin
por: Rodríguez, Ernesto, et al.
Publicado: (2017)

mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
por: Matarazzo, Laura, et al.
Publicado: (2023)

Gut Microbiota Abrogates Anti-α-Gal IgA Response in Lungs and Protects against Experimental Aspergillus Infection in Poultry
por: Mateos-Hernández, Lourdes, et al.
Publicado: (2020)

Functional Food for the Stimulation of the Immune System Against Malaria
por: Bamgbose, Timothy, et al.
Publicado: (2021)

Infection with Toxocara canis Inhibits the Production of IgE Antibodies to α-Gal in Humans: Towards a Conceptual Framework of the Hygiene Hypothesis?
por: Hodžić, Adnan, et al.
Publicado: (2020)

A dataset for the analysis of antibody response to glycan alpha-Gal in individuals with immune-mediated disorders
por: de la Fuente, José, et al.
Publicado: (2021)

α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
por: Zhang, Yingting, et al.
Publicado: (2019)

Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies
por: Galili, Uri
Publicado: (2021)

Anti-Microbiota Vaccine Reduces Avian Malaria Infection Within Mosquito Vectors
por: Aželytė, Justė, et al.
Publicado: (2022)

Immunomodulation resulting of helminth infection could be an opportunity for immunization against tuberculosis and mucosal pathogens
por: Chin, Kai Ling, et al.
Publicado: (2023)

Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS)
por: Vaz-Rodrigues, Rita, et al.
Publicado: (2022)

Conversion of Tumors into Autologous Vaccines by Intratumoral Injection of α-Gal Glycolipids that Induce Anti-Gal/α-Gal Epitope Interaction
por: Galili, Uri
Publicado: (2011)

ST6GAL1 and α2-6 Sialylation Regulates IL-6 Expression and Secretion in Chronic Obstructive Pulmonary Disease
por: Krick, Stefanie, et al.
Publicado: (2021)

The Formation of Glycan-Specific Natural Antibodies Repertoire in GalT-KO Mice Is Determined by Gut Microbiota
por: Bello-Gil, Daniel, et al.
Publicado: (2019)

Course of IgE to α‐Gal in a Swedish population of α‐Gal syndrome patients
por: Apostolovic, Danijela, et al.
Publicado: (2021)

Correlations between the alpha-Gal antigen, antibody response and calcification of cardiac valve bioprostheses: experimental evidence obtained using an alpha-Gal knockout mouse animal model
por: Naso, Filippo, et al.
Publicado: (2023)

Antibody production and tolerance to the α-gal epitope as models for understanding and preventing the immune response to incompatible ABO carbohydrate antigens and for α-gal therapies
por: Galili, Uri
Publicado: (2023)

Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities
por: Zhang, Xueying, et al.
Publicado: (2021)

Antibody responses to α-Gal in African children vary with age and site and are associated with malaria protection
por: Aguilar, Ruth, et al.
Publicado: (2018)

Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application
por: Coppola, Mariateresa, et al.
Publicado: (2018)

IgE, α-Gal and atherosclerosis
por: Wilson, Jeffrey M., et al.
Publicado: (2019)

Acceleration of Wound Healing by α-gal Nanoparticles Interacting with the Natural Anti-Gal Antibody
por: Galili, Uri
Publicado: (2015)

Blood-Borne ST6GAL1 Regulates Immunoglobulin Production in B Cells
por: Irons, Eric E., et al.
Publicado: (2020)

Functional Redundancy and Ecological Innovation Shape the Circulation of Tick-Transmitted Pathogens
por: Estrada-Peña, Agustín, et al.
Publicado: (2017)

The glycoprotein TRP36 of Ehrlichia sp. UFMG-EV and related cattle pathogen Ehrlichia sp. UFMT-BV evolved from a highly variable clade of E. canis under adaptive diversifying selection
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2014)

The Good, the Bad and the Tick
por: Cabezas-Cruz, Alejandro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qt8iko1f9iiv66do4j7sl3e682